Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to propofol versus isoflurane for deep vitrectomy
IRCT20201116049410N2Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in vitreoretinal disease (VRD) comparing Dexmedetomidine + propofol maintenance with Dexmedetomidine + isoflurane maintenance (2 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 7 more. Started Jun 2026; status: recruiting.
02
Drugs
dexmedetomidinepropofolisoflurane
03
Conditions
vitreoretinal disease (VRD)
Beyond the preview
Go deeper on IRCT20201116049410N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201116049410N2.